Cardiac Implants Market Share

  • Report ID: 4111
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Cardiac Implants Market Regional Analysis:

North America Market Insights  

North America industry is estimated to account for largest revenue share of 37% by 2035, attributed to increasing frequency of arrhythmias, and other heart diseases in the region. The growth of the market can be attributed majorly to the increasing frequency of arrhythmias, and other heart diseases in the region. For instance, around 12 million Americans are estimated to be diagnosed with atrial fibrillation by 2030. Further, the presence of a strong healthcare network in the region, along with the availability of a large pool of patients is also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of medical equipment are also anticipated to boost market growth .

Asia Pacific Market Insights  

On the other hand, the Asia Pacific cardiac implants market is also attributed to holding a significant market share during the analysis period on the account of growing geriatric population in the region who are at higher risk of cardiovascular diseases. Also, the high prevalence rate of cardiovascular diseases, and other heart-related disorders among the population is expected to boost the expansion of market size. Recent reports suggest that cardiovascular diseases were the leading cause of death in the Asia Pacific region taking up around 11 million lives in 2019, which is approximately 35% of the total death.

Cardiac-Implants-Market-Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cardiac implants is evaluated at USD 48.29 billion.

The global cardiac implants market size was worth around USD 44.86 billion in 2025 and is set to register a CAGR of more than 8.5%, exceeding USD 101.43 billion revenue by 2035.

North America cardiac implants market will hold around 37% share by 2035, driven by the high frequency of heart diseases and robust healthcare infrastructure.

Key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co., KG, ZOLL Medical Corporation, Medtronic plc, LivaNova PLC, Abbott Laboratories, MEDICO S.R.L., Lepu Medica.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos